Clariant AG/€CLN

1D1W1MYTD1Y5YMAX

About Clariant AG

Clariant AG is a global specialty chemicals company headquartered in Muttenz, Switzerland. The company operates through several segments including Care Chemicals, Catalysis, and Natural Resources. Care Chemicals focus on consumer goods, industrial applications, as well as agriculture, offering products such as surfactants and polymers. Catalysis provides solutions for the petrochemical and refining industries, while Natural Resources cover oil and mining services. Founded in 1995 as a spin-off from Sandoz, Clariant has expanded its geographic footprint across Europe, North America, Latin America, and Asia. Its strategic strength lies in developing innovative and sustainable solutions aimed at enhancing customer performance, with a strong focus on R&D and bespoke product offerings.
Ticker
€CLN
Sector
Materials
Primary listing
XGAT
Employees
10,107
Headquarters
Muttenz, Switzerland

Clariant AG Metrics

BasicAdvanced
€3.6B
-
-€0.11
0.45
€0.46
4.13%

Bulls say / Bears say

Q2 2026 EBITDA margin before exceptional items expanded by 80 basis points to 18.2%, driven by strong performance in Care Chemicals and Adsorbents & Additives, marking a clear improvement in profitability. (Clariant Q2 Press Release)
Care Chemicals segment sales increased 4.2% in local currency excluding portfolio pruning in Q2 2026 while Adsorbents & Additives grew 5.3%, collectively offsetting weakness in Catalysts and underpinning segment resilience. (Clariant Q2 Press Release)
In H1 2026, operating cash flow rose to CHF 168.7 million versus CHF 115.9 million in H1 2025 and free cash flow conversion improved to 52% LTM, bolstering the company’s liquidity and balance sheet strength. (Clariant Q2 Press Release)
Catalysts segment sales declined by 13.3% in Q2 2026 year-on-year due to volume headwinds from the ongoing Middle East conflict, posing a material drag on segment growth. (Clariant Q2 Press Release)
Including portfolio pruning measures, reported Q2 2026 sales fell 0.3% year-on-year in local currency, highlighting the risk of top-line contraction from portfolio streamlining. (Clariant Q2 Press Release)
H1 2026 EBITDA margin before exceptional items dipped to 17.8% from 18.1% in H1 2025, indicating nascent margin pressure despite segment offsets. (Clariant Q2 Press Release)
Data summarised monthly by Lightyear AI. Last updated on 26 Aug 2026.

Funds containing Clariant AG

AllEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.